Posts Tagged ‘minister’
If the Government Won’t Regulate Cannabis Then We’ll Do It For Them
The CBD Market
Educating And Influencing Researchers
For cannabis and drugs policy reform, out of 650 MPs, there could not have been a worse person to seize power than Theresa May. There are a few who come close on both Tory and Labour benches but no one who has such a long record of bigotry, denial of evidence and refusal even to consider the subject.
To be fair, I am a member of the Conservative Party, which to many people involved in the cannabis campaign is a mortal sin but my advocacy is based on science and evidence, not tribalism or wider politics. In any case, though many find this fact hard to accept, there has always been more support from Tory MPs than Labour. Highly influential and senior Tory MPs such as Crispin Blunt, Peter Lilley and Dr Dan Poulter are powerful advocates for reform. I firmly believe that the only sustainable route to legalisation is commercialisation and the left wing, nanny state, anti-business types are already pushing the ‘Big Cannabis’ scare stories.
So what can we do and what are we doing to advance our cause in these dark days? Theresa May always has been secretive, inaccessible, unresponsive and entirely disinterested in any opinion except her own. How can we possibly make any progress with a PM who has already shown she is prepared to cover up or falsify evidence and defines herself by her belief in a supernatural power?
There is more support for cannabis law reform in Parliament than ever before. It is now official policy of both the Liberal Democrats and the Scottish National Party. The support from Scotland is far more valuable than that from the discredited LibDems. With the added factors of Brexit and Scottish Independence, the SNP is in a powerful position to advance its policies. Also, in Ireland, both north and south, public support for medical cannabis reform is exploding. Michelle O’Neill, SinnFein’s new leader, has pledged medical cannabis reform if she is re-elected (though she has no power to do so!). Her negotiating position is immensely strong now that the problems at Stormont, the rise of Sinn Fein and the Brexit factor all combine to make a united Ireland a real possibility.
During the coalition government from 2010 to 2015, few doors were closed to us. Over that period, CLEAR conducted more meetings with ministers and senior politicians than the entire UK campaign had achieved in 50 years. Because we had support from the LibDems, and introductions from the Deputy Prime Minister, even Tory ministers were ready to see us, even if they were merely paying lip service. That all stopped with the election of a majority Conservative government and after Cameron stepped down the doors were slammed in our faces, bolted and double-locked. The campaign has been in the doldrums ever since. Or has it?
The last major achievement of the last few year’s campaigning was the release of the APPG report on medical cannabis in September 2016. Alongside it, Professor Mike Barnes, CLEAR advisory board member, published his review ‘Cannabis: The Evidence for Medical Use‘. To all impartial and reasonable observers, these documents should have initiated positive government action towards reform, even if it was only very limited in scope. But no, Theresa May didn’t leave it to Amber Rudd, her successor as home secretary, she stepped straight in herself on the day of publication, before she could even have read it and dismissed the report out of hand. This echoes the apocryphal story of James Callaghan, then PM, throwing the 1969 Wooton Report in the bin without even opening it. Such is the inertia and prejudice that has not softened at all amongst the bigots despite 45 years of science and research proving that there are better, safer, more beneficial options available on cannabis.
For now, individual lobbying of MPs is our only route to power. Over the years we have refined our approach to this and we know what works. Getting into ping pong correspondence with an MP is a waste of time. An initial letter or email needs to be followed up with a face-to-face meeting and a determined focus on getting a tangible result. What sort of result you should look for depends on your circumstances but getting your MP to arrange a meeting with a government minister should be your goal.
If you’re a medical user then you’ll want to meet a health minister, preferably the Secretary of State, if not a junior minister or perhaps an advisor to the Department of Health. Work with your MP to achieve the best result you can. Your MP doesn’t necessarily have to agree with you about cannabis but they should facilitate your communication with government, that’s their job. If you’re more interested in the economic or social benefits to be gained from reform, you could ask for an introduction to the Chancellor, a treasury or business minister, or someone at the Cabinet Office who is involved in policy development. CLEAR can usually provide someone to accompany you on meetings but this must be arranged in advance and agreed with your MP or whoever your appointment is with. Alternatively, we can provide advice over the telephone on how to approach the meeting, what to ask for and what evidence or supporting material to take with you.
If the Government Won’t Regulate Cannabis Then We’ll Do It For Them
With an intransigent government that does it all it can to evade engagement on this issue, there is more that CLEAR is already doing. If the government won’t take responsibility and regulate cannabis, then step by step we are going to do it for them. Someone has to, there is far too much harm and suffering caused by present policy.
The CBD Market
Through 2016 the CBD market in the UK really began to take off. These are products derived from industrial hemp, grown legally under licence that offer many of the therapeutic benefits of cannabis. They should, in fact, be more accurately termed low-THC cannabis as apart from crystals and a few, rare examples of isolated CBD, they are whole plant extracts and contain all the cannabinoids, terpenes, flavonoids and other compounds found in the plants from which they are made. Therefore they offer many of the ‘entourage effect’ benefits but with very low levels of THC. It was obvious though that this market was heading for problems. More and more dubious suppliers were starting up, many making brazen claims for the medical effects and benefits of their products and many without any product testing, quality assurance or honest customer service. The law was then and always has been crystal clear, you cannot make medical claims for a product without it being properly licensed or regulated. Inevitably, in June 2016 the MHRA stepped in and sent threatening letters to a number of CBD suppliers.
CLEAR took the initiative. We wrote to the MHRA requesting a meeting. We engaged with the leading CBD suppliers and our advisory board members Professor Mike Barnes and Crispin Blunt MP were quickly on the case. The story has already been extensively reported but now, nearly a year on, our efforts are coming to fruition. We led the approach to the MHRA and in the process created what is now the Cannabis Trades Association UK (CTAUK). It is now recognised by the MHRA, it has established a code of conduct and it is now the gold standard of quality, ethics and legality that can give anyone buying CBD products real peace of mind. There are still cowboys out there, making false claims, selling products that offer no real benefit and even endangering their customers with products that are illegal under the Misuse of Drugs Act 1971 or the Psychoactive Substances Act 2016. Now though, customers can go to the CTAUK website and choose a supplier that is operating legally, ethically and within the regulations that the industry itself has established. We expect the MHRA very shortly formally to endorse CTAUK members as legitimate suppliers of CBD products as food supplements.
Neither can we accept the government’s irresponsible and cruel policy towards people who need cannabis as medicine. So CLEAR has taken a further initiative. After Theresa May’s dismissal of the APPG report, we approached the Royal Colleges of medicine. We pointed out that whatever the government might say, around one million people are using cannabis as medicine. Doctors have a duty and an ethical responsibility to educate themselves on the subject and be able to provide properly informed care to their patients. Our efforts have borne fruit. Professor Mike Barnes and I have worked with Professor Nigel Mathers of the Royal College of GPs (RCGP). We will be producing a draft set of guidelines on medicinal cannabis for GPs which will go the next meeting of the RCGP Council and is planned for publication in June 2017. If the government won’t do it, we will and the medical profession agrees with us. This will be the greatest practical advance ever made in medical cannabis in the UK.
Educating And Influencing Researchers
The UK is the most prolific source of research into the harms of cannabis, particularly the tenuous links between cannabis and psychosis. Despite dozens of studies, mainly from the Institute of Psychiatry at King’s College Hospital, this has never been shown to be any more than statistical correlation. Most of these studies are confounded by tobacco use but the latest work from Professor Sir Robin Murray and his team shows an even stronger correlation between tobacco and psychosis than cannabis.
Across the world, UK scientists have become notorious for this scaremongering which seems little different from the ‘reefer madness’ hysteria. To be fair, much of this is down to the UK media which has barely advanced since the 1930s in its reporting. It provides the environment in which researchers are able to gain funding for research into cannabis harms but hardly ever for cannabis benefits.
CLEAR is now working with the Institute of Psychiatry to develop a new and more balanced way of surveying the effects of cannabis. Dr Musa Sami has asked us to advise on the construction of a questionnaire on which the Institute will base its future work.
Essentially, UK government policy on cannabis hasn’t altered since 1971. Despite the vast amount of new evidence published since then and revolutionary change, particularly on medicinal use, all across the world, successive governments have stubbornly and obstinately refused to consider any sort of reform.
It doesn’t matter which party has been in power, Conservative, Labour or the coalition, it’s a subject that ministers and MPs simply refuse to engage with. It’s easier that way for them and be in no doubt: laziness, fear of a media backlash and deeply ingrained prejudice are the key factors in this impasse.
We had the downgrade to class C in 2003 and then back up to B in 2009 but this was a turgid and useless effort. No notice was taken of any evidence arising from this experiment. It was enacted to enable police to concentrate more on class A drugs and reversed based on Gordon Brown’s ‘Presbyterian conscience’ and a grubby, corrupt deal with Paul Dacre to win the Daily Mail’s political support. In fact, use went down while cannabis was class C and back up again when it was upgraded but governments have no interest in facts or evidence on this subject, only in political expediency and spinning advantage with the media.
The clamour for medicinal access has increased enormously, just as the evidence for its safety and efficacy has become overwhelming. The UK is now virtually isolated amongst first world countries with a cruel, inhumane and anti-evidence policy which makes us a laughing stock with all who are properly informed. It’s not a laughing matter for the victims though. For those persecuted by this nasty policy it is tears, pain, suffering, disability – all of which could be alleviated to at least some extent just by a stroke of the Home Secretary’s pen. It is sickening that all those who have held that office over the last 45 years escape without any shame or opprobrium on their character.
CLEAR receives hundreds of letters and emails every year from people who have written to their MP about medicinal cannabis and it is astonishing that unlike almost every other policy, exactly the same words are used by all MPs. They slavishly repeat the Home Office line which is ruthlessly enforced across party lines.
There have been some subtle changes. The marketing authorisation issued for Sativex in 2010 has led to a minor change in the tired and inaccurate line ‘there is no medicinal value in cannabis’. It’s now become ‘there is no medicinal value in raw cannabis’. This is scientifically and factually incorrect. Pharmacologically, Sativex and the ‘raw’ plants from which it is made are identical. It is whole plant cannabis oil and its authorisation by the MHRA as an extract of THC and CBD is fundamentally dishonest. GW Pharmaceuticals reveals it contains more than 400 molecules, the MHRA says it only contains two and “unspecified impurities”.
More recently, and in the face of an explosion of supportive evidence, another line has been added. This states that ‘the UK has a well established process for the approval of medicines through the MHRA and that any company wishing to bring a medicinal cannabis product to market should follow this procedure. In fact, inside sources suggest that the government is very keen to see new cannabis-based medicines approved by the MHRA. It would take the wind out of the sails of the medical cannabis campaign
This is the very last excuse for denying access to medicinal cannabis. It is nothing but an excuse and one that is misleading and based on deception. If we can expose how weak, inappropriate and fake it is, the government will have nowhere else to hide.
Firstly, as demonstrated with Sativex, the MHRA process is incapable of dealing with a medicine that contains hundreds of molecules. It is designed by the pharmaceutical industry for regulating single molecule medicines, usually synthesised in a lab, which have the potential to be highly toxic. CLEAR rejects the tired, boring theory that ‘Big Pharma’ is engaged in a massive conspiracy to deny access to cannabis and to ‘keep people ill’ so it can continue to sell its products to the NHS. The MHRA isn’t engaged in such malevolent conduct, it’s simply incapable of properly evaluating a whole plant extract through its existing methods.
The bright, shining truth of this, that totally demolishes the government’s position, is that in every jusrisdiction throughout the world where medicinal cannabis has been legally regulated, it is through a special system outside pharmaceutical medicines regulation. Every other government that has recognised the enormous benefit that medicinal cannabis offers has come to the same conclusion: cannabis is a special case. It is far more complex but much, much safer than pharmaceutical products.
Of course, there is also the ludicrous status of cannabis as a schedule 1 drug, which prevents doctors from prescribing it. If it was moved to schedule 2, alongside heroin and cocaine, or to schedule 4 alongside Sativex (the logical choice), doctors could be prescribing it tomorrow and high-quality, GMP and EU regulated medicinal cannabis from Bedrocan would be immediately available.
So the MHRA is the final excuse, the last obstacle to a revolution in healthcare in the UK. We need an ‘Office of Medicinal Cannabis’ as there is in the Netherlands, or ‘Access to Cannabis for Medical Purposes Regulations’ as administered by Health Canada. Colorado has its ‘Medical Marijuana Registry Program’ and other US states have similar arrangements. Israel’s Ministry of Health has its ‘Medical Cannabis Unit’. In Australia, its equivalent of the MHRA, the Therapeutic Goods Administration, has established its own set of medical cannabis regulations.
This is now the most important factor in achieving medical cannabis law reform. Next time you contact your MP or in any advocacy or campaign work you do, this is where to focus your energy. Cannabis is a special case, it is not like other medicines. Once we can open the eyes to this truth the path ahead will be clear.
Today, Friday 9th October, in advance of Monday’s cannabis debate in Parliament, I met with Oliver Letwin, the Cabinet Office minister with responsibility for the implementation of government policy.
According to The Independent, Oliver Letwin is “probably the most powerful person in the government after the Prime Minister and Chancellor”. I first met with him back in July and he agreed to investigate the possibility of cannabis being available on prescription. When the cannabis debate was announced, I asked to see him again before the debate took place and he very generously arranged to see me just in time.
Monday’s debate will be the first time in nearly 50 years that MPs have had an opportunity to consider the subject. Throughout the world, more and more governments are waking up to the huge damage that cannabis prohibition causes. Nearly all the harms around cannabis are not caused by cannabis itself but the laws against it. Prohibition of anything for which there is huge demand inevitably creates a criminal market. More than three million people in the UK choose to use cannabis regularly. We consume more than three and a half tons every day and spend more than £6 billion every year, all of which goes into the black economy.
Since the early 20th century, acres of newsprint have been devoted to telling us how harmful cannabis can be. The alcohol industry fiercely guards its monopoly of legal recreational drug use. It has enormous influence in government and its £800 million annual advertising spend give it great power over the media.
But the truth is becoming clear. Scientific evidence and real world experience show that compared to alcohol and even common painkillers and over-the-counter medicines, cannabis is very, very safe. Concerns about mental health impacts are proven to be wildly overblown as cannabis use has escalated by many orders of magnitude but mental health diagnoses have remained stable. Increasingly, those responsible for drugs policy realise that abandoning this huge market to criminals only makes things worse. Criminals don’t care who they sell to or what they sell, so children and the vulnerable become their customers and their product becomes low quality, contaminated, often very high strength ‘moonshine’ varieties.
A Win Win Proposal To The UK Government On Cannabis.
Perhaps the most pernicious effect of cannabis prohibition is the denial of access to it a medicine. On this, Mr Letwin has been consulting with other ministers in the Department of Health and the Home Office. He says he is now convinced that there is a very positive future for cannabinoid medicines. As a result, I hope to be meeting again shortly with George Freeman MP, the Life Sciences Minister. I led a delegation of medicinal cannabis users to meet with him at the beginning of this year. Mr Letwin has indicated to me that it is Mr Freeman’s office that needs to deal with this, so I am hopeful of real progress in the near future.
Mr Letwin warned me that the debate itself will not produce any change in the law and I acknowledge this but it is part of the process that will eventually get us there. I suggested that there is a win win option that could be implemented very easily and quickly. There is huge pressure on the government to act but also great inertia and resistance to change from the old guard. I proposed that if cannabis could be moved out of schedule 1 of the Misuse of Drugs Regulations it would enable doctors to prescribe it and researchers more easily begin the task of developing and testing new products.
The great benefit this would offer to the government is that it would be seen to be responding to the evidence, being progressive and keeping up with the worldwide movement towards reform. However, for the more conservative thinkers, the ‘tough on drugs’ mantra would remain in place. Cannabis would still be a class B drug and all the same penalties would remain in force. Both sides of the debate could see this move as a success for their argument.
So we all look forward to the debate. As is normal practice, no government ministers will participate but I expect a Home office minister will give some sort of response. We are making progress. Revolution is not the British way but I do think we can continue with guarded optimism that our message is getting through and the direction of travel is certain.
Face it, this is exactly how too many people in Britain see medicinal cannabis users. It’s not true. It’s not fair. It’s unjust. Almost everything about it is wrong. The one thing that’s right – is that it’s a stereotype some people keep on reinforcing.
So we have to educate and inform those who have the power to change the law. We also have to adjust our aims and our expectations to be realistic in the eyes of those we need to persuade. It’s a big enough leap to convince people that cannabis can be a safe and effective medicine. In 2015, in the UK, the idea that we are going to convince politicians and medical policymakers that we “grow our own medicine” is fantasy. It is not going to happen.
Of course, many people have to grow their own at present because they have no choice. Particularly now that NICE have recommended against Sativex there is, for most people, no other option.
Effective campaigning is about focus, ruthless focus on a precise target. For medicinal cannabis, wider issues of human rights, individuality, ecology, lifestyle, – these are irrelevant. Do those some other time. Real and effective campaigning is like a job interview. You behave and dress in a way you believe will win you credit with your your prospective employer. That’s what we must do if we want to persuade people and change minds.
So the image of medicinal cannabis users we present is crucial. When government ministers see that we are ordinary, decent, hardworking people with families, careers, homes, pets, elderly relatives that we care about – and all we are trying to do is improve our health – that’s what makes the difference.
Believe me, I have seen it with my own eyes. When we first met Norman Baker last year, he was far from convinced about medicinal cannabis. He was pretty dubious about it in fact, as are many. He said initially there was only “limited evidence”. Only when he met some people and listened to their stories did he become open to considering the evidence that we offered. I swear, I actually watched his mind changing, particularly as he listened to Lara Smith explain how she copes with constant pain and bringing up three young children.
Later, Norman told me that when he spoke to Theresa May about it, she simply didn’t understand. She couldn’t conceive that these scumbag potheads and druggies have anything to do with the consumption of a therapeutic and beneficial plant.
It is a step too far to try and include GYO in the campaign for medicinal cannabis. We are simply laughed at. No one suggests growing opium poppies or willow trees or deadly nightshade to use as medicine. It undermines all the effort to provide good scientific evidence and a responsible, coherent argument. GYO cannot provide the standards of quality, consistency, safety (free from mould, fertiliser and pesticide residues, etc) that other medicines have to comply with.
Don’t get me wrong. I’m all for GYO but I’m a weirdo, one of those eccentrics who also grows his own tomatoes, potatoes and other vegetables. Most people prefer to buy them in Sainsbury’s and that’s exactly how it will be when cannabis is finally legalised. Most people will prefer it in a nice plastic tray with a film wrapper and a label telling them exactly what they are getting.
GYO must wait for wider decriminalisation or legalisation. Bringing it into the argument for permitting medicinal use is the cannabis campaign shooting itself in the foot – yet again!
Oliver Letwin MP is, according to The Independent, “probably the most powerful person in the government after the Prime Minister and Chancellor”.
He is the Cabinet Office minister with responsibility for the implementation of government policy. He holds the ancient title of Chancellor of the Duchy of Lancaster. He is a member of 13 of the 14 Cabinet committees and chair of three of them, more than anyone other than Cameron. He is now chair of the most powerful of them, the Home Affairs committee, which Theresa May would have expected to chair and he also sits on nine of the 10 new “Implementation Taskforces”. Cameron is said to have told him “I need you with me every day”.
An extraordinarily powerful and influential man. I met with him last week to put the case for reform of policy on medicinal cannabis. He listened attentively, asked searching questions, evidently has a good understanding of science and medicines regulation. In the end, he agreed to ask Jeremy Hunt, Secretary of State for Health, to meet with me and a delegation of medicinal cannabis users. We agreed that the Home Office is no longer the route to reform. The word is that if the Department of Health calls for a new policy then the Home Office will comply. Theresa May has been sidelined on this issue. Her minister of state for drugs policy, Mike Penning, seems to be nothing but a mouthpiece for Home Office civil servants. Quite properly and at last, medicinal cannabis is being seen as a health issue and not one of law enforcement or criminal justice.
So we could not have a more important opportunity. Mr Letwin has now confirmed to me in writing that he will “..investigate the question of prescription cannabis for relief of medical conditions. I will start the process of talking to people in MHRA, Public Health England and so forth to try to get a sense of the pros and cons.”
Although he has not yet indicated to me that he supports our cause, he seemed particularly perplexed that cannabis is a schedule 1 drug whereas heroin is schedule 2 and may be prescribed by a doctor. It is clear that he recognises there is medicinal value in cannabis.
To have Oliver Letwin pursuing our cause through government is great progress. Although the loss of our Liberal Democrat allies has been a setback, it seems that the issue of medicinal cannabis has momentum. We need to keep on keeping on. Nothing works better than getting in front of government minsters and showing them that most people who use medicinal cannabis are responsible members of society, doing the best they can to contribute, holding down a job where possible, looking after their families and trying to maintain their health.
I sense that the optimism we felt before the election was not misplaced. Engaging with government, turning away from irresponsible protest and putting our arguments forward with courtesy and evidence is what will achieve our goal.
CLEAR is launching a new recruitment drive for its Medicinal Cannabis Users Panel. If you use cannabis as medicine, joining the panel is the most effective thing you can do both to advance the campaign and, in some instances, gain legitimate access to prescribed Bedrocan medicinal cannabis.
The panel has proved itself to be the most effective campaigning method ever used in the UK. As a direct result of the efforts of panel members, in the last two years there have been more meetings with government minsters, officials and senior MPs than the whole campaign has managed in the last 50 years.
You must be a member of CLEAR to join the panel, then you complete a detailed questionnaire providing information on your condition(s) and how cannabis helps. Each applicant is then interviewed by telephone to develop an individual plan. This will depend on a number of factors, such as your relationship with your doctor, your MP, how much time you have available and whether you are prepared to tell your story to the media.
If your doctor is prepared to help, there is now an established route to getting medicinal cannabis prescribed and legally imported into the UK. CLEAR has developed this process through experience working with doctors, MPs, the Home Office and the Border Force. We also have crucial support from the All Party Parliamentary Group (APPG) on Drug Policy Reform and a number of members of the House of Lords. This is on a private prescription basis only. The prescription has to be very carefully written, using exactly the correct wording and, to begin with, you will have to travel to Holland in person to have the prescription dispensed at a pharmacy. Thereafter it may be possible to have repeat prescriptions sent through the post.
Bedrocan is the Dutch government’s official producer of medicinal cannabis. Five different varieties are available at a cost of approximately seven to eight euros per gram. See full details of the different products here.
All panel members are guided in how to approach their doctor and MP. Initial contact should be made by letter or email but then it is important to meet your doctor and MP face to face and provide them with high quality scientific evidence to support your case. CLEAR will offer guidance and help at every stage. If you wish then a member of our executive committee will accompany you to meetings to help you present your case. Whether or not your doctor is prepared to write a prescription for you, we aim to continue leading delegations of medicinal users to meet ministers. We have seen again and again what an impact this can have. When senior politicians who have no experience of medicinal cannabis meet genuine, decent, ordinary people with families and careers who tell their story with sincerity and conviction, it has an enormous impact.
If you live in the UK and are interested in joining the panel, please email a brief explanation of your interest to: email@example.com
Please do not go into great detail at this stage. Applications should be no more than 200 words. We will respond to you with a questionnaire within seven to 10 days.
Our principal allies on the Liberal Democrat benches have all lost their seats.
Quickly now, the government will be formed. No surprise that Theresa May has already been reappointed Home Secretary but who will the junior Home Office ministers be?
Brokenshire may leave for another department. He’s probably due for a promotion. It would be very good to see the back of him. Who will the Crime Prevention Minister be? Within that portfolio rests responsibility for drugs.
This is when the nightmare struck. Key candidates for Home Office ministers will be backbenchers who have sat on the Home Affairs Select Committee. I hardly dare write his name in case it puts ideas in Cameron’s mind – Michael Ellis.
Ellis is a hard line prohibitionist, anti-drugs, anti-liberty, anti-science, criminal barrister with a particular record of boorish behaviour during PMQs. He’s a junior barrister working out of chambers in Northampton and he thinks that his experience with a few scumbag dealers qualifies him to know all about drugs policy.
The idea is a nightmare. Cameron will see his increased number of seats as vindication of all past policies so he may well go further to the right. I hope I’m wrong. Perhaps we will get some young MP with a brain in his head and an eye for the free market economy that is blossoming in Colorado and elsewhere. Let’s hope so.
There’s also the new members of the Home Affairs Select Committee. Who will they be? We need to get to know them and present our case.
We must re-design, re-target, re-focus and refine our campaign for our new audience – Tory ministers are our most important targets.
Our messages must be developed for Tory eyes. More focus on the free market, profit opportunities, public expenditure savings. And our tactics must work with Tories as well. There is even less room now for the self-defeating tactics of protest, civil disobedience and flaunting alternative lifestyles in a way that distracts from our very powerful arguments. Such tactics might cause a right-wing backlash now.
Instead of being self-obsessed, as so much of the cannabis campaign is, if we want to be effective we must see things through the eyes of our target audiences, look outward not in, recognise that preaching to the choir achieves little. It is people who don’t agree with our cause that we must talk to and it is to their standards that we must dress and behave if we want to influence them.
Now, more than ever before, we need to be smart about the way we campaign for cannabis law reform. We do have allies in the Tory party and the worldwide momentum continues to build.
A few adjustments on the tiller are necessary but we remain on course. Let’s just be sure we adjust our sails and our technique for the new weather.